1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 11 MAY 2015

Key Pharma News 11 MAY 2015

  • May 2015
  • -
  • Espicom Business Intelligence
  • -
  • 33 pages

Industry Trend Analysis - EpiTherapeutics Acquisition Will Be Start Of Oncology Deals For Gilead In 2015
Industry Brief - OncoGenex Regains Rights To Custirsen From Teva
Industry Trend Analysis - Celgene's Haematology Expertise Will Benefit AstraZeneca
Industry Brief - Curadev/Roche Enter Cancer Immunotherapy Deal
Industry Brief - Innate/AstraZeneca To Co-Develop IPH2201 In Immuno-Oncology
Industry Trend Analysis - ViiV To Help GSK Weather A Tumultuous 2015
Industry Trend Analysis - Gilead Positioned To Make Key Acquisition
Industry Trend Analysis - GSK Oncology Additions To Increase Novartis' Growth Trajectory
Industry Trend Analysis - Biogen Will Continue To Gain Share Of MS Market
Industry Trend Analysis - Esbriet Sales Will Reach Blockbuster Status In 2016
Industry Brief - Teva Completes Acquisition Of Auspex Pharmaceuticals
Industry Trend Analysis - Outcome Of Perrigo-Mylan-Teva Tussle Will Shape The Generic Industry
Industry Trend Analysis - Diversification To Bolster Celgene's Revenues
Industry Trend Analysis - Tecfidera Will Be Leading MS Drug In 2015
Industry Brief - FDA Approves Ionsys For Acute Postoperative Pain
Industry Brief - Xarelto Gains Approval For Additional Indications In China
Industry Brief - Daiichi Sankyo's Once-Daily Lixiana Receives Positive CHMP Opinion
Industry Brief - FDA Approves Breo Ellipta For Asthma
Industry Brief - FDA Accepts Zinbryta BLA For MS
Industry Brief - Merrimack Completes NDA Submission To FDA For MM-398 In MPC
Industry Brief - Pernix Launches Zohydro ER With BeadTek
Industry Brief - Cresemba Launched In US For Invasive Aspergillosis/Mucormycosis
Industry Brief - Pomalyst Meets Accelerated Approval Requirements For r/r MM
Industry Brief - Vanda Receives Positive CHMP Opinion On Hetlioz For Non-24
Industry Brief - CHMP Adopts Positive Opinion On Opdivo For Advanced Melanoma
Industry Brief - Lilly's Cyramza Gains Fourth FDA Approval
Industry Trend Analysis - Generic Drug Pricing Investigation Unlikely To Produce Results Soon
Industry Trend Analysis - US Generic Aripiprazole Competition Will Stress Otsuka's Reliance On Brexpiprazole
Industry Brief - FDA Grants Opdivo Priority Review For Previously Untreated Advanced Melanoma
Industry Brief - Baxter Seeks EU Approval For MM-398 In Post-Gemcitabine MPC
Industry Trend Analysis - FDA Will Continue To Face Criticism Until Interchangeability And Naming Issues Are Resolved
Industry Trend Analysis - Gilead/AbbVie To Eradicate Niche Commercial Opportunities In HCV
Industry Trend Analysis - BMS To Retain Dominant Position In First-Line Advanced Melanoma Setting
Industry Brief - Follow-Up Announcement Made On Preliminary Findings From Lurasidone Phase III Study
Industry Trend Analysis - Oncolytic Immunotherapy Will Enter The Market In 2015
Industry Trend Analysis - GSK's Shingles Vaccine To Erode Sales Of Merck's Zostavax
Industry Brief - Arzerra Phase III Study Meets Primary Endpoint Of PFS In Relapsed CLL
Industry Brief - Single-Dose Dalvance Meets Primary/Secondary Endpoints In Phase III Study For ABSSSIs

Table Of Contents

Key Pharma News 11 MAY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.